Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By https://janiceiwov019005.blog2freedom.com/36286786/tirzepatide-a-promising-new-treatment-for-obesity